Executive Summary
This intelligence stream covers 14 filings related to India's MCA insolvency and restructuring landscape, with a dominant theme of corporate restructuring through NCLT-approved schemes and ongoing Corporate Insolvency Resolution Processes (CIRPs). A significant cluster involves Dr. Agarwal's Health Care Limited and Dr.
Agarwal's Eye Hospital Limited, which are pursuing a merger with multiple NCLT-convened meetings scheduled for July 2, 2026, indicating a major consolidation in the eye healthcare sector. The CIRP filings for Impex Ferro Tech, PS IT Infrastructure, Future Lifestyle Fashions, and Astron Paper & Board Mill reveal persistent stress, with the latter two showing severe operational shutdowns and auditor disclaimers. A critical outlier is the unrelated financial data for Nectar Lifesciences, which shows a massive 125% YoY widening of net losses to ₹29,288.48 Lakh, driven by discontinued operations. The Triton Valves amalgamation of a loss-making subsidiary into a profitable parent highlights a strategic move to absorb losses, while the Ramco Cements filing is a procedural step in a related-party restructuring. Overall, the filings paint a picture of active corporate restructuring, with a mix of strategic mergers and distressed CIRPs, requiring close monitoring of creditor and shareholder votes.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Insolvency · Corporate governance
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from May 30, 2026.
Investment Signals (10)
-
Multiple NCLT meetings scheduled for July 2, 2026, with e-voting from June 7 to July 1, 2026. This consolidation in the eye healthcare space could create synergies and improve market positioning. The scheme requires approval from shareholders and creditors, making the vote outcome a key catalyst.
- Triton Valves Ltd. Amalgamation ↓ (BULLISH)▲
The NCLT-approved scheme to amalgamate a loss-making subsidiary (cash loss of ₹180.13 lakh current year) into a profitable parent without issuing shares is a balance-sheet strengthening move. This could improve the parent's tax position and streamline operations.
- PS IT Infrastructure & Services CIRP (BULLISH)▲
The first CoC meeting confirmed a Resolution Professional and approved inviting Expressions of Interest (EOI). With total admitted claims of only ₹13.22 Crore, this is a small CIRP that may attract niche resolution applicants, offering a potential turnaround play.
- Impex Ferro Tech CIRP Extension▲
The 26th CoC meeting approved a 90-day extension and added two new Prospective Resolution Applicants (PRAs). The addition of new bidders could signal renewed interest and a potential resolution, though the repeated extensions indicate complexity. [NEUTRAL/BULLISH]
- Nectar Lifesciences (Unrelated Data in Dr. Agarwal's Filing) (BEARISH)▲
The company reported a net loss of ₹29,288.48 Lakh for FY ended March 31, 2026, a 125% increase from a loss of ₹13,008.90 Lakh in the prior year. Losses from discontinued operations surged to ₹23,554.37 Lakh, indicating a failed business exit strategy.
- Astron Paper & Board Mill CIRP (BEARISH)▲
The IRP approved audited results with a disclaimer of opinion. Plants are shut down (Halvad since Sep 2024), no production, and total bank dues of ₹87.61 Crore. This is a deep distress situation with high uncertainty, making equity recovery unlikely.
- Future Lifestyle Fashions CIRP (BEARISH)▲
The 36th CoC meeting indicates the CIRP has been ongoing since May 2023 (over 3 years), suggesting a prolonged and complex resolution process. The lack of a resolution plan after 36 meetings is a red flag for creditor recovery.
- Dr. Agarwal's Health Care Secured Creditors Meeting (NEUTRAL)▲
The scheme requires approval from a majority representing three-fourths in value of secured creditors. The outcome of this vote on July 2 is a critical binary event for the merger's success.
- Ramco Cements / Ramco Windfarms (NEUTRAL)▲
The NCLT allowed the first motion application for a scheme involving a related entity. This is a procedural step, but successful completion could unlock value through restructuring of wind energy assets.
- Dr. Agarwal's Eye Hospital Shareholder Meeting (BULLISH)▲
The cut-off date for voting eligibility is June 3, 2026. Investors holding shares before this date will have a direct say in the merger, making it a key date for arbitrage or event-driven strategies.
Risk Flags (9)
- ▼
Plants at Halvad (closed Sep 8, 2024) and Bhuj are shut with no production. No provisions for expected credit loss on trade receivables (Ind-AS 109) or gratuity liabilities (Ind-AS 19) have been made, indicating severe accounting and governance risks.
- Nectar Lifesciences / Widening Losses [HIGH RISK]▼
Net loss increased 125% YoY to ₹29,288.48 Lakh, with discontinued operations losses of ₹23,554.37 Lakh. The quarterly loss from continuing operations also worsened dramatically to ₹3,720.60 Lakh (vs ₹10.60 Lakh in Q4 FY25), signaling a fundamental business deterioration.
- Future Lifestyle Fashions / Prolonged CIRP↓ [HIGH RISK]▼
The 36th CoC meeting without a resolution plan after 3+ years (since May 2023) suggests a high risk of liquidation, which would result in minimal recovery for creditors and zero for equity holders.
- Impex Ferro Tech / Repeated CIRP Extensions↓ [MEDIUM RISK]▼
The approval of another 90-day extension (26th CoC meeting) indicates ongoing challenges in concluding the resolution process, increasing the risk of value erosion and eventual liquidation.
- Triton Valves / MSME Dues↓ [MEDIUM RISK]▼
Both the transferor and transferee companies have outstanding dues to Micro, Small and Medium Enterprises (MSMEs) totaling ₹993.93 lakh. This could lead to regulatory scrutiny or payment delays, impacting supplier relationships.
- PS IT Infrastructure / Small CIRP Size↓ [MEDIUM RISK]▼
With admitted claims of only ₹13.22 Crore, the CIRP may not attract serious resolution applicants, leading to a quick liquidation. The small size also means high legal costs relative to asset value.
- Dr. Agarwal's Merger / Creditor Approval Risk [MEDIUM RISK]▼
The scheme requires approval from secured creditors representing three-fourths in value. Any dissent from major creditors could derail the merger, creating downside risk for shareholders of both entities.
- Astron Paper & Board Mill / Auditor Disclaimer↓ [HIGH RISK]▼
The auditor issued a disclaimer of opinion due to multiple uncertainties, including shutdown and lack of provisions. This makes the financial statements unreliable and could hinder the CIRP process.
-
The inclusion of Nectar Lifesciences' poor financial results in the same filing as the merger notice is unusual and could indicate operational linkages or cross-entity risks that are not fully disclosed.
Opportunities (8)
- Dr. Agarwal's Health Care / Merger Arbitrage↓ (OPPORTUNITY)◆
With the shareholder and creditor meetings on July 2, 2026, and e-voting from June 7 to July 1, there is an opportunity for event-driven investors to capture potential price appreciation if the merger is approved. The cut-off date for voting eligibility is June 3, 2026.
- PS IT Infrastructure & Services / Small CIRP Turnaround↓ (OPPORTUNITY)◆
With admitted claims of only ₹13.22 Crore, this small CIRP could be resolved quickly if a suitable buyer emerges. The invitation for EOI is a first step, and investors with turnaround expertise could target this for a quick resolution.
- Impex Ferro Tech / New Resolution Applicants↓ (OPPORTUNITY)◆
The inclusion of two new entities in the final list of PRAs could bring fresh capital and a viable resolution plan. If a plan is approved, creditors and potentially equity holders (if the plan includes them) could see recovery.
- Triton Valves / Post-Amalgamation Synergies↓ (OPPORTUNITY)◆
The amalgamation of a loss-making subsidiary could allow Triton Valves to offset future profits with carried-forward losses, reducing tax liability. The appointed date of April 1, 2025, means these benefits may already be accruing.
- Ramco Cements / Related-Party Restructuring (OPPORTUNITY)◆
The NCLT's approval of the first motion for Ramco Windfarms could lead to a clean restructuring of wind energy assets, potentially unlocking value for Ramco Cements shareholders through improved capital efficiency.
- Dr. Agarwal's Eye Hospital / Consolidation Play (OPPORTUNITY)◆
The merger with Dr. Agarwal's Health Care creates a larger, more efficient entity in the eye healthcare market. Investors could buy shares before the July 2 vote to benefit from potential post-merger re-rating.
- Astron Paper & Board Mill / Asset Play↓ (OPPORTUNITY)◆
Despite the shutdown, the company has bank dues of ₹87.61 Crore against potentially valuable land and plant assets at Halvad and Bhuj. A resolution plan could involve asset sales, offering a recovery opportunity for distressed debt investors.
- Future Lifestyle Fashions / Distressed Debt Opportunity↓ (OPPORTUNITY)◆
With the CIRP ongoing for 3+ years, distressed debt investors could acquire creditor claims at a discount and participate in any eventual resolution or liquidation proceeds.
Sector Themes (6)
- Eye Healthcare Consolidation (HIGH ACTIVITY)◆
Four of the 14 filings relate to the merger of Dr. Agarwal's Eye Hospital and Dr. Agarwal's Health Care, indicating a major consolidation trend in the Indian eye healthcare sector. The multiple NCLT meetings and procedural filings suggest a well-planned merger that could set a precedent for other healthcare chains.
- Prolonged CIRPs and Extension Fatigue (NEGATIVE TREND)◆
Filings for Future Lifestyle Fashions (36th CoC meeting, 3+ years) and Impex Ferro Tech (26th CoC meeting, multiple extensions) highlight a systemic issue of delayed resolutions under IBC. This increases costs and reduces recovery rates for creditors, signaling a need for regulatory intervention.
- Operational Shutdowns in Manufacturing CIRPs (NEGATIVE TREND)◆
Astron Paper & Board Mill's plant shutdowns (Halvad since Sep 2024) and lack of production underscore the challenge of reviving stressed manufacturing assets. This contrasts with service-sector CIRPs (e.g., PS IT Infrastructure) which may be easier to resolve.
- Related-Party Restructuring vs. Third-Party CIRPs (POSITIVE TREND)◆
Triton Valves and Ramco Cements are pursuing related-party amalgamations/restructurings through NCLT, which are generally smoother and faster than third-party CIRPs. This theme suggests that companies prefer internal restructuring to avoid the uncertainties of IBC.
- Cross-Entity Financial Disclosures [RISK THEME]◆
The inclusion of Nectar Lifesciences' financial results in Dr. Agarwal's Health Care's filing is unusual and may indicate inter-company exposures or common promoters. This raises governance concerns and highlights the need for investors to scrutinize all data in filings, even if seemingly unrelated.
- Small-Ticket CIRPs Attracting Interest (OPPORTUNITY THEME)◆
PS IT Infrastructure's small CIRP (₹13.22 Crore claims) and the addition of new PRAs in Impex Ferro Tech suggest that smaller CIRPs may be more attractive to resolution applicants due to lower capital requirements and faster timelines.
Watch List (8)
-
NCLT-convened meetings on July 2, 2026, for shareholders and creditors to vote on the merger. E-voting runs June 7 to July 1. Outcome will determine the future of the combined entity.
- Impex Ferro Tech↓ (WATCH)👁
90-day CIRP extension approved; watch for resolution plan submissions from the two new PRAs. Next CoC meeting will be critical.
- PS IT Infrastructure & Services↓ (WATCH)👁
EOI invitation approved; monitor for receipt of resolution plans and any updates on the CIRP timeline.
- Astron Paper & Board Mill↓ (WATCH)👁
Auditor disclaimer and plant shutdowns make this a high-risk CIRP. Watch for any resolution plan or liquidation order from NCLT.
- Future Lifestyle Fashions↓ (WATCH)👁
36th CoC meeting held; watch for any breakthrough in resolution or move towards liquidation after 3+ years of CIRP.
- Nectar Lifesciences (WATCH)👁
Massive widening of losses (125% YoY) and discontinued operations losses warrant monitoring for any restructuring, debt default, or potential CIRP filing.
- Triton Valves↓ (WATCH)👁
Post-amalgamation integration and impact on financials. Watch for any regulatory issues related to MSME dues.
- Ramco Cements / Ramco Windfarms (WATCH)👁
Second motion application due within 14 days of NCLT order (received May 27, 2026). Watch for filing and subsequent NCLT hearing.
Filing Analyses
(14)
01-06-2026
The Hon'ble NCLT, Bengaluru Bench, has approved the Scheme of Arrangement for Amalgamation of Tritonvalves Climatech Private Limited (Transferor Company) with Triton Valves Limited (Transferee Company) with an appointed date of April 1, 2025. The Transferor Company is a wholly owned subsidiary of the Transferee Company, and no shares will be issued as consideration. Notably, the Transferor Company is a loss-making entity (cash loss of Rs.180.13 lakh in the current year and Rs.317.47 lakh in the previous year) amalgamating with a profit-making Transferee Company, and both companies have outstanding dues to Micro, Small and Medium Enterprises (MSMEs) totaling Rs.56.63 lakh and Rs.937.30 lakh respectively.
- · The appointed date for the scheme was changed from April 1, 2023 to April 1, 2025 following observations from the Official Liquidator.
- · The Transferor Company is a wholly owned subsidiary of the Transferee Company, with the Transferee Company holding 99.99% equity in the Transferor Company.
- · Mrs. Anuradha Maruti Gokam holds 26.66% major equity shares in the Transferee Company.
- · The Transferor Company was originally incorporated on January 14, 2020; the Transferee Company on September 10, 1975.
- · Both companies have open charges and must obtain No Objection Certificates from charge holders.
- · The Transferee Company is listed on BSE Limited (Scrip Code: 505978).
- · The Transferor Company has incurred cash losses of Rs.180.13 lakh (current year) and Rs.317.47 lakh (previous year).
- · The Transferee Company is a profit-making entity.
- · Outstanding MSME dues: Transferor Company Rs.56.63 lakh, Transferee Company Rs.937.30 lakh.
- · Undisputed statutory dues of Transferor Company: Rs.7.67 lakh (Note 17) and Rs.34.03 lakh (Note 22) as per FY24 financials.
- · No open complaints, prosecutions, or investigations are pending against either company with the ROC.
- · The scheme involves no issue of shares as consideration; the 10,000 equity shares of Rs.10 each held by the Transferee Company in the Transferor Company will be cancelled.
- · Employees of the Transferor Company will be transferred to the Transferee Company upon scheme approval.
01-06-2026
Dr. Agarwal's Health Care Limited has dispatched physical letters to equity shareholders and creditors without registered email addresses, providing web-link and QR code to access notices for meetings convened by NCLT Chennai to consider a Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited. The equity shareholders meeting is scheduled for July 2, 2026 at 12:30 PM, and the unsecured creditors meeting on the same day at 4:00 PM, both at The Music Academy, Chennai. Remote e-voting runs from June 7 to July 1, 2026.
- · Cut-off date for sending notice to eligible equity shareholders: May 22, 2026
- · Cut-off date for determining eligibility for e-voting (equity shareholders): June 3, 2026
- · Cut-off date for sending notice to unsecured creditors: December 31, 2025
- · Remote e-voting period: June 7, 2026 (9:00 AM IST) to July 1, 2026 (5:00 PM IST)
- · Meetings are physical (non-virtual) at The Music Academy, Chennai.
01-06-2026
Dr. Agarwal's Eye Hospital Limited has dispatched physical letters to equity shareholders and creditors without registered email addresses, providing web-link and QR code access to the Notice for the upcoming meetings convened by the NCLT Chennai Bench. The meetings are scheduled for July 2, 2026, to consider and approve the proposed Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited. This is a procedural disclosure under Regulation 30 of SEBI LODR, with no financial figures or performance data included.
- · Equity Shareholders meeting: Thursday, July 2, 2026 at 09:00 A.M. IST at The Music Academy, T.T.K. Road, Chennai.
- · Unsecured Creditors meeting: Thursday, July 2, 2026 at 11:30 A.M. IST at the same venue.
- · Cut-off date for sending Notice to eligible shareholders: Friday, May 22, 2026.
- · Cut-off date for determining eligibility for e-Voting for shareholders: Wednesday, June 3, 2026.
- · Cut-off date for sending Notice to eligible unsecured creditors: Wednesday, December 31, 2025.
- · Remote e-Voting period: Sunday, June 7, 2026 at 9:00 A.M. IST to Wednesday, July 1, 2026 at 5:00 P.M. IST.
- · Meetings are held in physical mode as per NCLT Chennai Bench directions.
- · Shareholders and creditors have the right to request a physical copy of the Notice free of cost.
01-06-2026
Dr. Agarwal's Health Care Limited has published a joint newspaper advertisement for NCLT-convened meetings of shareholders and creditors scheduled for July 2, 2026, regarding a scheme of amalgamation with Dr. Agarwal's Eye Hospital Limited. The filing also includes an extract of audited financial results for Nectar Lifesciences Limited (not directly related to the primary company) showing a significant full-year net loss from continuing and discontinued operations of ₹29,288.48 Lakh, compared to a loss of ₹13,008.90 Lakh in the prior year, driven by massive losses from discontinued operations.
- · The NCLT-convened meetings for shareholders, secured creditors, and unsecured creditors are scheduled on July 2, 2026.
- · Dr. Agarwal’s Health Care Limited has issued a joint newspaper advertisement in Business Standard (English) and Makkal Kural (Tamil).
- · Nectar Lifesciences’ net loss after tax from discontinued operations for FY ended March 31, 2026 was ₹23,554.37 Lakh, versus a loss of ₹12,998.30 Lakh in the prior year.
- · Nectar Lifesciences’ paid-up share capital declined from ₹2,242.61 Lakh to ₹1,942.61 Lakh YoY, indicating possible capital reduction or buyback.
- · Dr. Agarwal’s Health Care Limited’s registered office is in Chennai (CIN L85100TN2010PLC075403).
- · The filing mentions a special Lok Adalat organized in Chennai for settlement of pending loan accounts/pledge matters.
01-06-2026
Dr. Agarwal's Eye Hospital Ltd. has issued a joint newspaper advertisement convening meetings of equity shareholders, secured creditors, and unsecured creditors on July 02, 2026, as directed by the NCLT, Chennai Bench, to consider a Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The filing also includes an extract of audited financial results for Nectar Lifesciences Limited (unrelated entity) showing a net loss of ₹29,288.48 Lakh for the year ended March 31, 2026, compared to a loss of ₹13,008.90 Lakh in the prior year, indicating a significant widening of losses.
- · The NCLT convened meetings are scheduled for July 02, 2026 at The Music Academy, Chennai.
- · The Scheme of Amalgamation is between Dr. Agarwal's Eye Hospital Ltd. (Transferor Company No. 1) and Dr. Agarwal's Health Care Ltd. (Transferee Company).
- · Nectar Lifesciences Ltd. reported a net loss from continuing operations of ₹3,720.60 Lakh for the quarter ended March 31, 2026, compared to a loss of ₹10.60 Lakh in the same quarter last year.
- · Nectar Lifesciences' total comprehensive income for the year ended March 31, 2026 was a loss of ₹29,280.56 Lakh, compared to a loss of ₹12,954.92 Lakh in the prior year.
- · The filing includes a notice to shareholders of ADC India Communications Ltd. regarding the second 100-day campaign 'Saksham Niveshak' for unclaimed dividends and KYC updation.
01-06-2026
The Ramco Cements Limited has informed the exchanges that the National Company Law Tribunal (NCLT), Chennai Bench, on 27 May 2026, allowed the first motion application filed by Ramco Windfarms Limited (a related entity) in connection with an insolvency proceeding. The NCLT has directed Ramco Windfarms Limited to file the second motion application within 14 days of receiving the order. This is a procedural update following earlier letters dated 5 November 2025 and 17 March 2026.
- · The NCLT order was dated 27 May 2026.
- · The first motion application was filed by Ramco Windfarms Limited, not by The Ramco Cements Limited directly.
- · This is a continuation of earlier disclosures dated 5 November 2025 and 17 March 2026.
01-06-2026
Impex Ferro Tech Limited, currently under Corporate Insolvency Resolution Process (CIRP), held its 26th Committee of Creditors (CoC) meeting on May 29, 2026. The meeting approved a 90-day extension of the CIRP timeline, inclusion of two new entities in the final list of Prospective Resolution Applicants (PRAs), and the quarterly/annual financial results for the period ended March 31, 2026. The extension indicates ongoing challenges in concluding the resolution process.
- · The 26th CoC meeting was held on May 29, 2026, from 12:00 to 12:40 hours.
- · Minutes were circulated via email on May 30, 2026, at 16:01 hours.
- · The CIRP extension of 90 days was approved through circulation prior to the meeting.
- · AIC Iron Industries Private Limited and Ankoor Distillers Private Limited were approved for inclusion in the Final List of PRAs.
- · The quarterly/annual financial results for the period ended March 31, 2026, were approved.
- · Ashok Kumar Sarawagi is the Resolution Professional with IBBI Registration No. IBBI/IPA-001/IP-P00171/2017-18/10340.
- · The AFA validity is December 30, 2026.
01-06-2026
PS IT Infrastructure & Services Limited has commenced Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016, with the first meeting of the Committee of Creditors (CoC) held on May 25, 2026. The CoC comprises 11 financial creditors with total admitted claims of ₹13,22,45,825 (₹13.22 Crore), and has confirmed Rajneesh Kumar Aggarwal as Resolution Professional. Key resolutions include appointment of legal counsel, registered valuers, transaction auditor, and approval to invite Expressions of Interest (EOI) for resolution of the corporate debtor.
- · CIRP commenced on 29th April, 2026 under NCLT Case No. (IB)/1232(MB)2025.
- · Total claimed amount by financial creditors was ₹13,24,80,086, but admitted amount is ₹13,22,45,825 (difference of ₹2,34,261 not admitted).
- · Voting was conducted via e-voting from 27th May 2026 (4 PM) to 29th May 2026 (4 PM).
- · The meeting duration was only 19 minutes (02:30 PM to 02:49 PM IST).
- · Resolutions include: appointment of RP, approval of IRP/RP remuneration, CIRP costs, going concern expenses, shorter notice period for future meetings (48 hours), appointment of legal counsel, extension of minimum interval between CoC meetings to 60 days, appointment of registered valuers, appointment of transaction auditor, and approval of EOI process.
- · Lookback period for transaction audit is set from 01.04.2024 to 29.04.2026.
01-06-2026
Dr. Agarwal's Health Care Limited (AHCL) has issued a notice convening a meeting of its equity shareholders on July 2, 2026 to seek approval for a Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited (AEHL), where AEHL will merge into AHCL. The meeting was directed by the NCLT, Chennai Bench via its order dated May 5, 2026. Key documents including valuation reports, fairness opinions, and observation letters from stock exchanges (NSE and BSE) have been provided to shareholders ahead of the vote.
- · The NCLT convened meeting of Equity Shareholders of AHCL will be held on Thursday, July 2, 2026 at 12:30 P.M. IST at The Music Academy, T.T.K. Road, Chennai - 600 014.
- · Remote e-voting period: June 7, 2026 (9:00 AM IST) to July 1, 2026 (5:00 PM IST).
- · Cut-off date for voting eligibility: Wednesday, June 3, 2026.
- · Share valuation cum share exchange ratio report dated August 26, 2025, issued jointly by PwC Business Consulting Services LLP and Bansi S. Mehta Valuers LLP has been provided as Annexure II.
- · Fairness opinions dated August 26, 2025, from Kotak Mahindra Capital Company Limited and Motilal Oswal Investment Advisors Limited have been provided (Annexure IIIA and IIIB).
- · NSE and BSE issued observation letters conveying no adverse observations/no-objection for the Scheme on February 16, 2026 and February 17, 2026 respectively.
01-06-2026
Dr. Agarwal's Health Care Limited (AHCL) has issued a notice convening a meeting of its Secured Creditors on July 2, 2026, to consider and approve a Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited (AEHL) and AHCL, as directed by the Hon'ble NCLT, Chennai Bench. The meeting will be held at The Music Academy, Chennai, with remote e-voting available from June 7 to July 1, 2026. The scheme, if approved by a majority representing three-fourths in value of secured creditors, will be subject to further regulatory approvals.
- · The NCLT order was dated May 5, 2026, and the notice was filed on June 1, 2026.
- · The cut-off date for determining eligible secured creditors is December 31, 2025.
- · The remote e-voting period runs from June 7, 2026 (9:00 AM IST) to July 1, 2026 (5:00 PM IST).
- · The meeting venue is The Music Academy, T.T.K. Road, Chennai – 600 014.
- · The scheme involves amalgamation of AEHL (transferor) into AHCL (transferee).
- · The share valuation cum share exchange ratio report was issued on August 26, 2025, by PwC Business Consulting Services LLP and Bansi S. Mehta Valuers LLP.
- · Fairness opinions were provided by Kotak Mahindra Capital Company Limited and Motilal Oswal Investment Advisors Limited on August 26, 2025.
- · Observation letters from NSE (February 16, 2026) and BSE (February 17, 2026) conveyed no adverse observations/no-objection.
- · The resolution requires approval by a majority in number representing three-fourths in value of secured creditors casting votes.
- · The scheme is subject to subsequent approval by the NCLT and other regulatory authorities.
01-06-2026
Future Lifestyle Fashions Limited (under CIRP) held its 36th Committee of Creditors meeting on 29th May 2026, as intimated to stock exchanges. The company remains under corporate insolvency resolution process since May 2023, with Ravi Sethia as Resolution Professional.
- · The company has been under CIRP since NCLT order dated 04th May 2023 (CP(IB) No. 959/MB/2022).
- · Ravi Sethia was confirmed as Resolution Professional in the first CoC meeting on June 6, 2023.
- · The filing is made under Regulation 30 of SEBI LODR and sub-clause 16(g) of Clause A of Part A of Schedule III.
01-06-2026
Dr. Agarwal's Eye Hospital Limited (AEHL) has issued a notice convening a meeting of its secured creditors on July 2, 2026, to consider and approve a scheme of amalgamation with Dr. Agarwal's Health Care Limited (AHCL). The meeting is being held pursuant to an order from the National Company Law Tribunal (NCLT), Chennai Bench, dated May 5, 2026. The scheme, if approved by the requisite majority of secured creditors, will be subject to further approval by the NCLT and other regulatory authorities.
- · The NCLT order was dated May 5, 2026.
- · The meeting of secured creditors will be held on July 2, 2026, at 10:30 AM IST at The Music Academy, Chennai.
- · Remote e-voting period runs from June 7, 2026 (9:00 AM IST) to July 1, 2026 (5:00 PM IST).
- · The cut-off date for eligibility to vote is December 31, 2025.
- · The scheme requires approval by a majority in number representing three-fourths in value of the secured creditors present and voting.
- · The share valuation cum share exchange ratio report was issued on August 26, 2025, by PwC Business Consulting Services LLP and Bansi S. Mehta Valuers LLP.
- · Fairness opinions were obtained from Kotak Mahindra Capital Company Limited and Motilal Oswal Investment Advisors Limited, both dated August 26, 2025.
- · Observation letters from NSE (February 16, 2026) and BSE (February 17, 2026) conveyed no adverse observations/no-objection.
- · The statutory auditors' certificates on accounting treatment were issued by Deloitte Haskins & Sells on August 27, 2025.
01-06-2026
Dr. Agarwal's Eye Hospital Limited (AEHL) has issued a notice for a meeting of equity shareholders on July 2, 2026, to consider and approve a scheme of amalgamation with Dr. Agarwal's Health Care Limited (AHCL). The meeting is convened pursuant to an order from the National Company Law Tribunal (NCLT) dated May 5, 2026. The scheme involves amalgamation of AEHL into AHCL, and shareholders will vote on the proposal via remote e-voting or in person.
- · The meeting will be held physically at The Music Academy, T.T.K. Road, Chennai on July 2, 2026 at 09:00 AM IST.
- · Remote e-voting period runs from June 7, 2026 (09:00 AM IST) to July 1, 2026 (05:00 PM IST).
- · Cut-off date for voting eligibility is June 3, 2026.
- · The scheme includes a share valuation cum share exchange ratio report dated August 26, 2025, and fairness opinions from Kotak Mahindra Capital and Motilal Oswal Investment Advisors.
- · Observation letters from NSE and BSE were issued on February 16 and 17, 2026, conveying no adverse observations.
01-06-2026
Astron Paper & Board Mill Limited is undergoing Corporate Insolvency Resolution Process (CIRP) under IBC. The IRP approved audited financial results for Q4 and FY ended March 31, 2026, with the auditor issuing a disclaimer of opinion due to multiple uncertainties. The company has total bank dues of ₹87.61 Crore as of March 31, 2026, plants are shut down, and no production occurred during the quarter.
- · Plants at Halvad and Bhuj are shut down; Halvad plant closed since September 8, 2024, and no production resumed.
- · No provision made for expected credit loss on trade receivables as per Ind-AS 109.
- · No provision for gratuity liabilities as per Ind-AS 19.
- · Inventories of imported raw materials at port not accounted; some auctioned without recognition in books.
- · Outstanding balances of bank loans, receivables, payables are subject to confirmation and reconciliation.
- · The company's going concern status is substantially adversely affected; auditor states financials should not be prepared on a going concern basis.
Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 14 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India MCA Insolvency Liquidation Filings
🇮🇳 More from India
View all →June 02, 2026
India Quarterly Results BSE NSE Announcements — June 02, 2026
India Quarterly Results BSE NSE Announcements
June 02, 2026
India Upcoming Corporate Actions BSE NSE — June 02, 2026
India Upcoming Corporate Actions BSE NSE
June 02, 2026
India Pre-Market Regulatory Roundup — June 02, 2026
India Pre-Market Regulatory Roundup
June 02, 2026
BSE Realty Real Estate Sector Regulatory Filings — June 02, 2026
BSE Realty Real Estate Sector Regulatory Filings